Leg cramps are not listed as a recognized adverse effect in FDA prescribing information for semaglutide
Most people experience fatigue during the initial weeks of GLP-1 treatment, particularly during dose titration, with improvement occurring over several weeks to months as the body adapts
GLP-1 medications like Semaglutide and Tirzepatide are approved in many countries worldwide, though sometimes under different brand names or through different manufacturers
Rosenstock J, Fonseca V, Schinzel S et al (2014) Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: evidence from a long-term controlled trial
That means next-day air may refer to the carrier method after shipment, not the total time from checkout to delivery
Nausea, diarrhea, and vomiting were the most common events